Showing results (31-40 of 64) with videos related to

Sort By:
Pageof 7
Menopause (New York, N.Y.)|December 29, 2012
Breast density changes in a randomized controlled trial evaluating bazedoxifene/conjugated estrogensJennifer A Harvey, JoAnn V Pinkerton, Edmund C Baracat, et al.
Current Medical Research and Opinion|May 14, 2004
Two-year efficacy and tolerability of risedronate once a week for the treatment of women with postmenopausal osteoporosisS T Harris, N B Watts, Z Li, et al.
Bone|March 10, 2000
Improvement of pagetic bone lesions with risedronate treatment: a radiologic studyJ P Brown, A A Chines, W R Myers, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|October 17, 2007
Fracture risk remains reduced one year after discontinuation of risedronateN B Watts, A Chines, W P Olszynski, et al.
The Journal of Clinical Endocrinology and Metabolism|January 21, 2014
Effects of bazedoxifene/conjugated estrogens on the endometrium and bone: a randomized trialJoann V Pinkerton, Jennifer A Harvey, Robert Lindsay, et al.
Pediatric Radiology|May 1, 1997
Metachondromatosis: report of a family with facial features mildly resembling trichorhinophalangeal syndromePediatr Radiol 1997 Nov;27(11):864T E Herman, A Chines, W H McAlister, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 11, 2010
Efficacy and safety of bazedoxifene in postmenopausal Asian womenL Xu, K-S Tsai, G S Kim, et al.
Obstetrics and Gynecology|May 3, 2013
Breast effects of bazedoxifene-conjugated estrogens: a randomized controlled trialJoAnn V Pinkerton, Jennifer A Harvey, Kaijie Pan, et al.
Journal of Women'S Health (2002)|November 12, 2013
Evaluation of the efficacy and safety of bazedoxifene/conjugated estrogens for secondary outcomes including vasomotor symptoms in postmenopausal women by years since menopause in the Selective estrogens, Menopause and Response to Therapy (SMART) trialsJoann V Pinkerton, Lucy Abraham, Andrew G Bushmakin, et al.
Menopause (New York, N.Y.)|June 24, 2009
Bazedoxifene effects on the reproductive tract in postmenopausal women at risk for osteoporosisJoAnn V Pinkerton, David F Archer, Wulf H Utian, et al.
Pageof 7